Chronic Pain Treatment Market: Trends, Growth, and Leading Solutions in 2025 | Top key players - Novartis AG, Johnson & Johnson, Sanofi SA.

The Global Chronic Pain Treatment Market reached US$ 83.8 billion in 2022 and is expected to reach US$ 143.2 billion by 2030 growing with a CAGR of 7.1% during the forecast period 2024-2031.

Chronic Pain Treatment Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

The Chronic Pain Treatment Market focuses on therapies designed to manage long-term pain conditions, such as arthritis, neuropathy, and fibromyalgia. With an increasing prevalence of these conditions, the market includes medications, physical therapies, and innovative treatments like nerve stimulation and biologics. Rising awareness and advancements in personalized pain management strategies continue to drive market growth globally.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/chronic-pain-treatment-market?sz

Market opportunities and Growth Drivers:

Rising FDA Approvals for Neurostimulation Device is Expected to Drive Global Chronic Pain Treatment Market

Recent advancements in neurostimulation devices are making a significant difference for patients dealing with chronic neurological disorders. These devices work by applying electrical stimulation to activate neural circuits, offering a promising solution for managing chronic pain.

A major factor driving the growth of the chronic pain treatment market is the continuous innovation and new product launches in this field. For example, on March 23, 2023, Neuspera Medical, a US-based company specializing in neuromodulation devices, received approval from the US Food and Drug Administration (FDA) for its next-generation Neuspera ultra-miniaturized system. This new system is designed to deliver peripheral nerve stimulation (PNS) in a more wireless, less invasive, and versatile way compared to existing technologies, marking a significant leap forward in pain management.

These advancements are not only improving patient care but are also helping to drive the growth of the neurostimulation and chronic pain treatment markets.

Chronic Pain Treatment Market Recent Development:

Abbott's Spinal Cord Stimulation Device Gains FDA Approval for Chronic Back Pain Treatment

On May 16, 2023, Abbott announced that its spinal cord stimulation (SCS) device received approval from the U.S. Food and Drug Administration (FDA) for the treatment of chronic back pain. This device is particularly beneficial for individuals who either haven't been able to undergo surgery or are not candidates for surgical intervention. The FDA's approval was supported by positive results from a clinical study, which showed that Abbott's proprietary BurstDR SCS technology helped improve pain levels, daily activity performance, and emotional well-being for patients with chronic back pain.

CombiGene Partners with Zyneyro to Develop Chronic Pain Treatments

On January 11, 2023, CombiGene, a gene therapy company, entered into a collaboration with the Danish biotech firm Zyneyro to further develop treatments for chronic pain conditions. CombiGene's pipeline includes CG01, aimed at treating drug-resistant epilepsy, and CGT2, which targets lipodystrophy. In addition, CombiGene secured an exclusive collaboration and licensing deal worth up to $328.5 million with U.S.-based Spark Therapeutics for the development of CG01, marking a significant milestone in advancing gene therapy options for patients.

List of the Key Players in the Chronic Pain Treatment Market:

Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Novartis AG, Johnson & Johnson, Sanofi SA, Teva Pharmaceutical Industries Ltd, Baxter International, Merck & Co. Inc, Boston Scientific Corporation among Others.

Research Process:

Both primary and secondary data sources have been used in the global Chronic Pain Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/chronic-pain-treatment-market

Segment Covered in the Chronic Pain Treatment Market:

By Indication: Neuropathic Pain, Analgesic Infusion, Ablation Devices.

By Product Type: Drugs, Devices.

By Distribution Channel: Hospital, Clinics, Ambulatory Centers.

Regional Analysis for Chronic Pain Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Chronic Pain Treatment Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Chronic Pain Treatment market?

➠ Who are the top manufacturers in the global Chronic Pain Treatment industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Chronic Pain Treatment market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Chronic Pain Treatment market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Chronic Pain Treatment industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/chronic-pain-treatment-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.